Skip to main content
International Health logoLink to International Health
. 2025 Sep 12;18(2):305–309. doi: 10.1093/inthealth/ihaf102

Strengthening antimicrobial resistance surveillance across African military settings

Yusuff Adebayo Adebisi 1,2,✉
PMCID: PMC13017221  PMID: 40966566

Abstract

While antimicrobial resistance (AMR) surveillance within civilian health systems has progressed, military health systems remain under-represented in related research and policy frameworks. Military personnel, particularly during deployments, often operate in environments characterised by combat-related injuries, overcrowding and inadequate sanitation, which increase the risk of spread and emergence of drug-resistant infections. Despite these vulnerabilities, national AMR strategies in Africa largely prioritise civilian systems, with minimal integration of military health surveillance data or clinical insights from military medical facilities. As a result, AMR trends within military populations and conflict zones remain poorly documented. This paper examines the distinctive AMR challenges in African military settings and proposes strategies for incorporating military medical surveillance data into national AMR frameworks. Drawing on international models, such as the US Armed Forces Health Surveillance Division's Antimicrobial Resistance Monitoring and Research programme, it highlights the potential for military facilities to serve as sentinel sites for resistance monitoring. Integrating military medical surveillance data into national systems would enhance understanding of resistance patterns and support more inclusive and effective containment strategies, while strengthening antimicrobial stewardship within military health facilities to reduce inappropriate antimicrobial use.

Keywords: Africa, antimicrobial resistance, military healthcare, surveillance


Antimicrobial resistance (AMR) is a major public health concern in Africa, exacerbated by the combined burden of infectious diseases, non-communicable conditions and injuries.1–3 While surveillance in civilian healthcare has expanded through initiatives such as the Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP),4 military settings remain largely unexamined. For the purposes of this paper, ‘military settings’ refers to the full range of environments in which armed forces personnel live, work and receive healthcare, including military health facilities (field hospitals, base clinics), deployment environments (conflict zones, peacekeeping missions, training camps), living quarters (barracks, temporary camps) and operational theatres where combat or humanitarian assistance takes place. Military personnel face distinct drug-resistant infection risks due to combat-related trauma, overcrowded barracks and deployments in areas with poor sanitation.5,6 These conditions are intensified by operational demands and may facilitate the emergence and spread of resistant pathogens.

Despite these risks, national AMR strategies and the African Union Framework for AMR Control (2020–2025) focus almost entirely on civilian systems.7 To the best of my knowledge, there has been no prior Africa-wide synthesis of AMR in military settings, leaving a critical gap in the evidence base. Neglecting AMR data from military settings creates blind spots in national and regional surveillance, allowing resistant pathogens circulating among armed forces to spread undetected into civilian populations and across borders, which may undermine broader containment efforts.

Military settings in Africa may contribute to AMR due to context-specific risk factors. As summarised in Table 1, these environments expose personnel to a range of priority pathogens, from Acinetobacter baumannii in combat wounds to Vibrio cholerae in humanitarian deployments. Combat injuries, which are common in conflict zones, often require prolonged antibiotic use, a recognised driver of resistance.8–10 Armed conflict increases the incidence of trauma requiring antibiotic treatment and disrupts medical supply chains, infection-prevention practices and laboratory services, thereby compounding the risk of resistant infections.10 Surveillance gaps make it difficult to quantify antimicrobial misuse or track resistance trends.

Table 1.

Potential target pathogens for AMR surveillance in African military settings

Pathogen Clinical significance Military-relevant settings Notes
Acinetobacter baumannii Causes wound and bloodstream infections; frequently MDR Field hospitals treating combat injuries Common in military wounds
Methicillin-resistant Staphylococcus aureus (MRSA) Skin, soft tissue and invasive infections; colonisation risk Barracks, training camps High transmission in crowded living quarters
Escherichia coli (ESBL-producing) Urinary and bloodstream infections; ESBL producers Deployed personnel in sanitation-poor field conditions Reflects local enteric resistance patterns
Klebsiella pneumoniae (CRE) Pneumonia, wound and bloodstream infections; carbapenem-resistant ICUs in mobile hospitals Emerging CRE clones threaten treatment options
Pseudomonas aeruginosa Wound and respiratory infections; often MDR Burn units, field ICUs Environmental organism, thrives in moist settings
Mycobacterium tuberculosis Pulmonary TB; MDR-TB increasing Barracks, peacekeeping deployments High TB burden in many deployment regions
Salmonella enterica (typhoidal) Typhoid fever; potential outbreaks in camps Field kitchens, large troop gatherings Indicator of hygiene and water quality
Vibrio cholerae Cholera outbreaks; rapid spread in displaced populations Refugee camps, areas with disrupted water/sanitation infrastructure Sentinel of severe waterborne risk
Staphylococcus pseudintermedius/Escherichia coli (veterinary) Opportunistic and zoonotic infections in humans; can be MDR Military working dogs, horses and livestock in operational bases Highlights One Health AMR risks from animal–human interfaces

AMR: antimicrobial resistance; CRE: Carbapenem-resistant Enterobacteriaceae; ESBL: extended-spectrum β-lactamase; MDR: multidrug-resistant.

Where military-specific data are available, they highlight important concerns. For example, a recent study in Nigerian Navy hospitals found antibiotics prescribed in 46.3% of encounters, exceeding the WHO/International Network for Rational Use of Drugs (WHO/INRUD) threshold of <30%.11 Similarly, an analysis of 11 590 prescriptions across three Nigerian military hospitals reported antibiotic use well above WHO/INRUD reference limits, with significantly higher rates during the COVID-19 period compared with prepandemic levels.12 Further evidence from Military Hospital Lagos showed that 93.8% of respiratory tract infection cases were upper respiratory, yet only 3% of patients underwent laboratory testing before antibiotic prescription, underlining diagnostic gaps that can drive unnecessary antibiotic use.13 These findings highlight substantial antibiotic prescribing pressures in African military facilities, which may be even greater in conflict-affected or resource-limited settings.10 Without targeted stewardship and surveillance interventions, these prescribing patterns risk accelerating the emergence and spread of multidrug-resistant pathogens within and beyond military populations.

Furthermore, overcrowded barracks can increase transmission risk, while troop movements across borders may facilitate regional spread. In addition, military operations may also involve the care and management of animals, including working dogs, horses and, in some contexts, livestock, which can introduce additional AMR risks through veterinary antibiotic use and potential zoonotic transmission. These animal–human interfaces in military settings reflect One Health concerns and underline the need for integrated surveillance approaches. Civil–military transmission can also occur when military hospitals treat civilian patients during emergencies,11 or when demobilised personnel return to densely populated urban areas, potentially carrying resistant organisms acquired during deployment. International data show that multidrug-resistant organisms (MDROs), including A. baumannii, are prevalent in combat-related wounds from Iraq and Afghanistan,14 raising concerns about similar patterns in African deployments. Military personnel often operate in areas with high burdens of TB, malaria and cholera, potentially compounding exposure to resistant pathogens. In the absence of targeted surveillance, the contribution of African military settings to AMR transmission remains poorly defined. Closing this gap is necessary to inform both military and public health strategies.

Africa's AMR national action plans, aligned with WHO and Africa Centres for Disease Control and Prevention (CDC) frameworks, primarily address civilian healthcare systems, with limited consideration for military contexts.15,16 Where military health policies do exist, they are often not publicly accessible, and data on service members or veterans are seldom integrated into national surveillance efforts.17 This omission may reflect both limited resources and the prioritisation of civilian systems due to their broader population coverage. However, military personnel interact regularly with civilian populations during and after deployments, creating potential pathways for transmission of resistant pathogens. Integrating these data streams will require addressing security concerns, protecting sensitive information and ensuring interoperability between civilian and military surveillance platforms. Including military settings in AMR surveillance could improve data completeness and support more comprehensive national response strategies.

A 2017 review identified 144 studies on AMR prevalence and susceptibility patterns in human bacterial pathogens across Africa, none of which focused specifically on military contexts.18 Research in this area is constrained by the restricted availability of military health data, which are often classified. Surveillance may also be hindered by military operations, which can disrupt laboratory activities and data collection, compounding the evidence gap. Even within civilian systems, diagnostic capacity is severely limited; the MAAP's 14-country analysis found that only 1.3% of 50 000 laboratories could perform bacteriology,4 suggesting that military medical facilities may face even greater limitations. In the absence of data from military facilities, national estimates rely on civilian proxies that may not accurately represent military operational environments. Closing this evidence gap is essential to determine whether military settings contribute meaningfully to AMR transmission and to guide the development of targeted intervention strategies. Early steps could include piloting sentinel AMR surveillance sites in selected military bases, beginning with peacekeeping operations and high-turnover training camps, before scaling to national coverage.

International experience underlines the importance of AMR surveillance in military settings. In the USA, the Antimicrobial Resistance Monitoring and Research (ARMoR) programme tracks MDROs across military facilities and has documented resistance trends in deployed personnel.19 European studies report Enterobacteriaceae colonisation in 4.7% of returning German soldiers, linking deployment to acquisition of resistant pathogens.20 These findings illustrate that military environments, characterised by trauma, high antibiotic use and frequent mobility, can facilitate AMR transmission. Military personnel often serve in regions with high infectious disease burdens and may reflect local resistance profiles.21,22 The use of broad-spectrum antibiotics is common in military healthcare and is often empirical due to limited diagnostic capacity.23–26 However, data on prescribing practices and resistance outcomes in African military contexts are lacking. The US Military Health System's experience with inconsistent diagnostic testing suggests that similar or greater challenges likely exist in under-resourced African settings.27 Targeted surveillance could help characterise AMR patterns, identify emerging clones such as carbapenem-resistant Enterobacterales and inform regionally adapted responses. Key policy actions to address these gaps are summarised in Table 2.

Table 2.

Recommendations for strengthening AMR surveillance in African military settings

Recommendation Rationale Potential implementing partners
1. Establish a military AMR task force Coordinates surveillance, standardises data and facilitates civil–military collaboration Ministries of defence, ministries of health, Africa CDC
2. Integrate military health data into national AMR plans Ensures that AMR data from soldiers and field hospitals contribute to national and regional strategies National AMR coordinating committees, WHO, Africa CDC
3. Deploy mobile diagnostic laboratories in conflict zones and barracks Enhances real-time detection of resistant pathogens where conventional laboratories are unavailable Military medical corps, Africa CDC, international NGOs
4. Conduct targeted operational research on AMR in military settings Fills key evidence gaps on pathogen prevalence, antimicrobial use and transmission risks Military research units, academic institutions, public health agencies
5. Build laboratory capacity within military health facilities Improves in situ bacteriological testing and reduces reliance on empirical antibiotic use Ministries of defence, Global Fund, AMR Donor Consortium
6. Include military personnel in regional AMR training and stewardship programmes Aligns prescribing behaviour with national guidelines and promotes shared best practices Africa CDC, WHO, regional training institutions
7. Monitor AMR risks among peacekeeping and returning personnel Addresses transmission pathways between military and civilian populations AU Peace and Security Department, national AMR programmes
8. Secure dedicated funding for AMR surveillance in military settings Ensures sustainable implementation of surveillance, capacity building and operational research Ministries of defence, Africa CDC, African Development Bank, AMR Multi-Partner Trust Fund, bilateral donors

AMR: antimicrobial resistance; AU: African Union; CDC: Centres for Disease Control and Prevention; NGO: non-government organisation.

Global initiatives such as the US ARMoR programme offer a potential model for Africa. A dedicated military AMR task force could be established in collaboration with the Africa CDC to support integration of military health data into national surveillance systems. Without such coordination, gaps in AMR reporting will persist, limiting the effectiveness of regional containment strategies. Expanding surveillance to include military facilities, particularly those supporting peacekeeping operations, would improve data coverage and inform more comprehensive policy responses.

Conclusion

Military settings in Africa remain a neglected component of AMR surveillance. Integrating data from these contexts into national systems could improve completeness and help identify resistance trends that may otherwise go undetected. Lessons from other regions suggest that military facilities can complement civilian surveillance networks, but implementation will require careful consideration of security, interoperability and ethical data governance. Incremental, well-coordinated approaches could strengthen both military and civilian AMR responses across the continent. To close this gap, the Africa CDC should formally incorporate military health surveillance into the next African Union AMR framework and require its integration into country-level National Action Plans, ensuring that military data collection, analysis and reporting are embedded in both national and regional strategies from the outset.

Author’s contributions

YAA conceptualised the article, prepared the initial draft, reviewed and revised the manuscript. YAA has undertaken all the duties of authorship and is guarantor of the paper.

Funding

None.

Competing interests

None declared.

Ethical approval

Not required.

Data availability

Not applicable.

References

  • 1. Gahimbare  L, Muvunyi  CM, Guessennd  NAK  et al.  Antimicrobial resistance in the WHO African region: a systematic literature review 2016-2020. Antibiotics. 2024;13(7):659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Antimicrobial Resistance Collaborators . The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis. Lancet Glob Health. 2024;12(2):e201–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Kariuki  S, Kering  K, Wairimu  C  et al.  Antimicrobial resistance rates and surveillance in sub-Saharan Africa: Where are we now?  Infect Drug Resist. 2022;15:3589–609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Reports. Available from: https://africacdc.org/download/mapping-antimicrobial-resistance-and-antimicrobial-use-partnership-maap-country-reports/ [last accessed August 4, 2025].
  • 5. Leaking Roofs, Stinking Toilets… Barracks Life For Nigerian Soldiers And Their Relatives. Available from: https://humanglemedia.com/leaking-roofs-stinking-toilets-barracks-life-for-nigerian-soldiers-and-their-relatives/ [last accessed August 4, 2025].
  • 6. South Africa's army is in steady decline and nothing's being done to fix it. Available from: https://theconversation.com/south-africas-army-is-in-steady-decline-and-nothings-being-done-to-fix-it-74712 [last accessed August 4, 2025].
  • 7. African Union Framework for Antimicrobial Resistance Control 2020–2025. Available from: https://africacdc.org/download/african-union-framework-for-antimicrobial-resistance-control-2020-2025/ [last accessed August 4, 2025].
  • 8. Asgedom  AA, Etsedingl  A, Hailemariam  TT  et al.  Prevalence, causes and outcomes of war-related civilian injuries in Ethiopia's war-torn Tigray region: a community-based descriptive study. BMC Res Notes. 2023;16(1):352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Arslan  E, Mohamed  AH, Cetinkaya  O. Terror-related injuries in Somalia: a retrospective cohort of 2426 hospitalized cases along 7 years. Sci Rep. 2022;12(1):17213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Granata  G, Petersen  E, Capone  A  et al.  The impact of armed conflict on the development and global spread of antibiotic resistance: a systematic review. Clin Microbiol Infect. 2024;30(7):858–65. [DOI] [PubMed] [Google Scholar]
  • 11. Mohammed  AS, Ogunnowo  BE, Odegbemi  OB. Knowledge, attitudes, and practices of rational drug prescribing in Nigerian Navy. Discover Public Health. 2025;22(1):413. [Google Scholar]
  • 12. Abubakar  MM, Loosli  K, Isah  A  et al.  Assessing the impact of COVID-19 on prescription patterns and antibiotic use: insights from three military health facilities. Res Social Adm Pharm. 2024;20(2):157–62. [DOI] [PubMed] [Google Scholar]
  • 13. Haruna  MA, Kute  NS, Ifediora  ES  et al.  Antimicrobial drug prescription patterns for respiratory tract infections in Military Hospitals Lagos Nigeria.  Nigerian J Pharmacy. 2022;56(2). [Google Scholar]
  • 14. Calhoun  JH, Murray  CK, Manring  MM. Multidrug-resistant organisms in military wounds from Iraq and Afghanistan. Clin Orthop Relat Res. 2008;466(6):1356–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Varma  JK, Oppong-Otoo  J, Ondoa  P  et al.  Africa Centres for Disease Control and Prevention's framework for antimicrobial resistance control in Africa. Afr J Lab Med. 2018;7(2):830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Gulumbe  BH, Haruna  UA, Almazan  J  et al.  Combating the menace of antimicrobial resistance in Africa: a review on stewardship, surveillance and diagnostic strategies. Biol Proced Online. 2022;24(1):19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. The Global Politics of Military Health in Africa. Available from: https://qmro.qmul.ac.uk/xmlui/handle/123456789/90907 [last accessed August 4, 2025].
  • 18. Tadesse  BT, Ashley  EA, Ongarello  S  et al.  Antimicrobial resistance in Africa: a systematic review. BMC Infect Dis. 2017;17(1):616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Lesho  EP, Waterman  PE, Chukwuma  U  et al.  The antimicrobial resistance monitoring and research (ARMoR) program: the US Department of Defense response to escalating antimicrobial resistance. Clin Infect Dis. 2014;59(3):390–7. [DOI] [PubMed] [Google Scholar]
  • 20. Frickmann  H, Wiemer  D, Frey  C  et al.  Low enteric colonization with multidrug-resistant pathogens in soldiers returning from deployments- experience from the years 2007-2015. PLoS One. 2016;11(9):e0162129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Ho  ZJ, Hwang  YF, Lee  JM. Emerging and re-emerging infectious diseases: challenges and opportunities for militaries. Mil Med Res. 2014;1:21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Pankok  F, Fuchs  F, Loderstädt  U  et al.  Molecular epidemiology of Escherichia coli with resistance against third-generation cephalosporines isolated from deployed German soldiers-a retrospective assessment after deployments to the African Sahel region and other sites between 2007 and 2016. Microorganisms. 2022;10(12):2448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Abou Fayad  A, Rizk  A, El Sayed  S  et al.  Antimicrobial resistance and the Iraq wars: armed conflict as an underinvestigated pathway with growing significance. BMJ Glob Health. 2023;7(Suppl 8):e010863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Stewart  L, Li  P, Blyth  MDM  et al.  Antibiotic practice patterns for extremity wound infections among blast-injured subjects. Mil Med. 2020;185(Suppl 1):628–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Petfield  JL, Lewandowski  LR, Stewart  L  et al.  IDCRP combat-related extremity wound infection research. Mil Med. 2022;187(Suppl 2):25–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Parker  M, Baluku  M, Ozunga  BE  et al.  Epidemics and the military: responding to COVID-19 in Uganda. Soc Sci Med. 2022;314:115482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Ashbaugh  H, Pomeroy  CD, Baishya  M  et al.  Antimicrobial resistance of enteric pathogens in the Military Health System, 2009–2019. BMC Public Health. 2022;22(1):2300. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Not applicable.


Articles from International Health are provided here courtesy of Oxford University Press

RESOURCES